You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for cupric sulfate; manganese sulfate; selenious acid; zinc sulfate and what is the scope of patent protection?

Cupric sulfate; manganese sulfate; selenious acid; zinc sulfate is the generic ingredient in two branded drugs marketed by Am Regent and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Cupric sulfate; manganese sulfate; selenious acid; zinc sulfate has six patent family members in six countries.

One supplier is listed for this compound.

Summary for CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE
Generic Entry Date for CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE*:
Constraining patent/regulatory exclusivity:
Dosage:
SOLUTION;INTRAVENOUS

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Pharmacology for CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE
Paragraph IV (Patent) Challenges for CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
TRALEMENT Injection cupric sulfate; manganese sulfate; selenious acid; zinc sulfate 0.3 mg/mL, 55 mcg/mL, 60 mcg/mL, 3 mg/mL (5 mL) 209376 1 2023-11-16
TRALEMENT Injection cupric sulfate; manganese sulfate; selenious acid; zinc sulfate 0.3 mg/mL, 55 mcg/mL, 60 mcg/mL, 3 mg/mL (5 mL) 209376 3 2023-11-14

US Patents and Regulatory Information for CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Am Regent TRALEMENT cupric sulfate; manganese sulfate; selenious acid; zinc sulfate SOLUTION;INTRAVENOUS 209376-001 Jul 2, 2020 RX Yes Yes 11,975,022 ⤷  Start Trial ⤷  Start Trial
Am Regent MULTRYS cupric sulfate; manganese sulfate; selenious acid; zinc sulfate SOLUTION;INTRAVENOUS 209376-003 Jun 30, 2021 RX Yes Yes 12,150,957 ⤷  Start Trial ⤷  Start Trial
Am Regent TRALEMENT cupric sulfate; manganese sulfate; selenious acid; zinc sulfate SOLUTION;INTRAVENOUS 209376-002 Dec 2, 2020 RX Yes Yes 11,975,022 ⤷  Start Trial ⤷  Start Trial
Am Regent TRALEMENT cupric sulfate; manganese sulfate; selenious acid; zinc sulfate SOLUTION;INTRAVENOUS 209376-001 Jul 2, 2020 RX Yes Yes 11,998,565 ⤷  Start Trial Y ⤷  Start Trial
Am Regent TRALEMENT cupric sulfate; manganese sulfate; selenious acid; zinc sulfate SOLUTION;INTRAVENOUS 209376-001 Jul 2, 2020 RX Yes Yes 11,786,548 ⤷  Start Trial Y ⤷  Start Trial
Am Regent MULTRYS cupric sulfate; manganese sulfate; selenious acid; zinc sulfate SOLUTION;INTRAVENOUS 209376-003 Jun 30, 2021 RX Yes Yes 11,786,548 ⤷  Start Trial Y ⤷  Start Trial
Am Regent TRALEMENT cupric sulfate; manganese sulfate; selenious acid; zinc sulfate SOLUTION;INTRAVENOUS 209376-002 Dec 2, 2020 RX Yes Yes 12,150,956 ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE

Country Patent Number Title Estimated Expiration
South Korea 20230058047 ⤷  Start Trial
Australia 2021300384 Trace element compositions, methods of making and use ⤷  Start Trial
Australia 2021300384 ⤷  Start Trial
European Patent Office 4175615 COMPOSITIONS D'OLIGO-ÉLÉMENTS, LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION (TRACE ELEMENT COMPOSITIONS, METHODS OF MAKING AND USE) ⤷  Start Trial
World Intellectual Property Organization (WIPO) 2022006426 ⤷  Start Trial
South Korea 20230058047 미량 원소 조성물, 그 제조 및 사용 방법 ⤷  Start Trial
Canada 3186578 COMPOSITIONS D'OLIGO-ELEMENTS, LEURS PROCEDES DE FABRICATION ET D'UTILISATION (TRACE ELEMENT COMPOSITIONS, METHODS OF MAKING AND USE) ⤷  Start Trial
>Country >Patent Number >Title >Estimated Expiration

Market overview for Cupric Sulfate, Manganese Sulfate, Selenious Acid, and Zinc Sulfate

Last updated: February 14, 2026

The global market for these industrial and pharmaceutical compounds is governed by diverse factors, including agricultural demand, pharmaceutical applications, industrial use, and regulatory shifts. Their market performances differ regionally, influenced by raw material availability, manufacturing capacity, regulatory environments, and application-specific demand drivers.


Cupric Sulfate (CuSO₄): Market Size and Trends

Cupric sulfate, widely used in agriculture (fungicide, herbicide), water treatment, and as a molluscicide, has an estimated global market size of over $2 billion in 2022. The compound's market is expected to grow at a compound annual growth rate (CAGR) of 4.2% from 2023 to 2030.

Regional drivers include:

  • North America: High adoption in water treatment.
  • Asia-Pacific: Leading in agricultural use due to expanding farming activities.

Key factors influencing growth include increased demand for fungicides, regulatory compliance for water treatment, and sustainable pest control practices. Market expansion is limited by environmental regulations regarding copper accumulation, especially in water and soil.

Market dynamics:

Factor Impact
Agricultural use Growing demand for crop protection boosts market
Water treatment Stringent regulations increase demand
Eco-regulation Limits on copper accumulation pose constraints

Manganese Sulfate (MnSO₄): Market Size and Trends

Manganese sulfate is used primarily in animal feed, fertilizers, and industrial applications such as battery manufacturing. The market size stood at approximately $1.3 billion in 2022, projected to grow at a CAGR of 3.8% through 2030.

Key regional markets:

  • China: Major producer and consumer due to large agricultural sector.
  • North America & Europe: Demand driven by animal husbandry standards and fertilizer use.

Growth drivers include the rising demand for manganese in lithium-ion batteries and bioavailability enhancements in agriculture. Challenges include toxicity concerns and fluctuating raw material prices.

Market dynamics:

Factor Impact
Battery industry Increasing demand for manganese in lithium-ion batteries
Agriculture Continued need for micronutrients enhances market
Regulatory issues Concerns over manganese toxicity influence regulatory landscape

Selenious Acid (H₂SeO₃): Market Size and Trends

Selenious acid's niche applications include pharmaceuticals, dietary supplements, and research chemicals. Its global market size was approximately $400 million in 2022, with an expected CAGR of 5.0% up to 2030, driven by growing interest in selenium supplementation.

Market growth is concentrated in:

  • North America: High supplement consumption.
  • Europe: Increased pharmaceutical applications.

Supply constraints stem from limited selenium extraction capacity and environmental concerns over selenium mining. The compound's market is sensitive to regulatory policies surrounding selenium use in supplements and pharmaceuticals.

Market dynamics:

Factor Impact
Nutritional supplementation Rising health awareness fuels demand
Pharmaceutical use Selenium-based drugs and diagnostics increase consumption
Supply constraints Tightening environmental and mining regulations impact availability

Zinc Sulfate (ZnSO₄): Market Size and Trends

Zinc sulfate remains a versatile compound used in agriculture (fertilizers), animal feed, and healthcare products. The global market was valued at around $1.7 billion in 2022, growing at a CAGR of 4.5% through 2030.

Primary demand regions include:

  • Asia-Pacific: Largest consumer due to extensive agriculture.
  • North America and Europe: Strong pharmaceutical market for zinc supplements.

Growth is driven by increasing zinc supplementation in livestock, expanding organic farming practices, and zinc's antiviral properties. Constraints involve zinc ore resource limitations and environmental regulations around mining and processing.

Market dynamics:

Factor Impact
Agriculture and animal feed Sustains demand with increased focus on nutrition
Healthcare Zinc's role in immune health boosts supplement sales
Regulatory environment Stricter mining and environmental policies may limit supply

Summary of Key Market Drivers and Constraints

Compound Key Drivers Constraints
Cupric sulfate Agriculture, water treatment, pest control Environmental regulators on copper buildup
Manganese sulfate Battery manufacturing, agriculture Toxicity, raw material prices
Selenious acid Supplements, pharmaceuticals Limited supply, regulatory scrutiny
Zinc sulfate Agriculture, health, nutrition Mining restrictions, resource limitations

Financial Trajectory Outlook

Most compounds exhibit steady growth driven by industrial and pharmaceutical applications. The primary financial considerations include raw material costs, regulatory compliance expenses, and shifts in end-use markets.

Compared to general market growth, the pharmaceutical segment's CAGR for selenious acid and zinc sulfate is higher due to increasing health and nutritional demand, despite supply constraints. The agricultural segment for cupric sulfate and zinc sulfate benefits from expanding crop protection needs but faces increasing environmental regulations.

Investment opportunities exist in manufacturing capacity expansion, particularly in regions with favorable regulatory environments and raw material access. Early adoption of sustainable practices and innovative formulations may provide competitive advantages.


Key Takeaways

  • Cupric sulfate’s growth is shaped by agriculture and water treatment needs but faces tightening environmental regulations.
  • Manganese sulfate is increasingly relevant in batteries and agriculture, with supply chain considerations.
  • Selenious acid’s niche lies in health and pharmaceuticals, with a supply constrained by selenium sourcing.
  • Zinc sulfate remains vital for nutrition and agriculture, with growth influenced by health trends and resource management.
  • Overall market growth remains stable, around 3.8%-5.0% annually, with regional variations affecting opportunities and risks.

FAQs

1. Which compound offers the highest market growth potential?
Selenious acid could outperform others due to increasing selenium supplementation and pharmaceutical application growth.

2. How do regulatory policies impact these compounds?
Stringent environmental regulations, especially for copper and zinc mining, limit supply expansion; pharmaceutical and supplement regulations influence market entry and innovation.

3. Are raw material shortages a concern?
Yes. Selenium and zinc resource constraints could disrupt supply chains, especially if environmental policies tighten globally.

4. What is the outlook for sustainable production practices?
Sustainable practices, including recycling and cleaner extraction techniques, are emerging as market differentiators, especially in copper and zinc sectors.

5. Who are the major producers?
Major producers include China, India, and countries in Europe and North America. Chinese capacity dominates manganese sulfate and zinc sulfate markets, while selenium production is concentrated in the US and China.


Sources

  1. Market Research Future, "Global Cupric Sulfate Market," 2022.
  2. Grand View Research, "Manganese Sulfate Market Size, Share & Trends," 2022.
  3. Persistence Market Research, "Selenious Acid Market," 2022.
  4. Markets and Markets, "Zinc Sulfate Market," 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.